1. Home
  2. ORN vs DVAX Comparison

ORN vs DVAX Comparison

Compare ORN & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc. Common

ORN

Orion Group Holdings Inc. Common

HOLD

Current Price

$10.69

Market Cap

409.8M

Sector

Industrials

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$11.02

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
DVAX
Founded
1994
1996
Country
United States
United States
Employees
1887
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.8M
1.3B
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
ORN
DVAX
Price
$10.69
$11.02
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$11.25
$26.50
AVG Volume (30 Days)
219.4K
1.7M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$835,917,000.00
$330,514,000.00
Revenue This Year
$6.40
$24.63
Revenue Next Year
$3.28
$15.85
P/E Ratio
$44.56
N/A
Revenue Growth
7.02
26.73
52 Week Low
$4.64
$9.20
52 Week High
$11.49
$14.63

Technical Indicators

Market Signals
Indicator
ORN
DVAX
Relative Strength Index (RSI) 64.29 51.72
Support Level $9.67 $10.79
Resistance Level $10.66 $11.10
Average True Range (ATR) 0.49 0.31
MACD 0.09 -0.07
Stochastic Oscillator 94.17 35.79

Price Performance

Historical Comparison
ORN
DVAX

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: